Research Output per year
Fingerprint Dive into the research topics where Bruno Amati is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 17 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
An early Myc-dependent transcriptional program orchestrates cell growth during B-cell activation
Tesi, A., de Pretis, S., Furlan, M., Filipuzzi, M., Morelli, M. J., Andronache, A., Doni, M., Verrecchia, A., Pelizzola, M., Amati, B. & Sabò, A., Sep 1 2019, In : EMBO Reports. 20, 9, e47987.Research output: Contribution to journal › Article
MYC in Germinal Center-derived lymphomas: Mechanisms and therapeutic opportunities
Bisso, A., Sabò, A. & Amati, B., Mar 2019, In : Immunological Reviews. 288, 1, p. 178-197 20 p.Research output: Contribution to journal › Review article
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value
Santoro, A., Vlachou, T., Luzi, L., Melloni, G., Mazzarella, L., D'Elia, E., Aobuli, X., Pasi, C. E., Reavie, L., Bonetti, P., Punzi, S., Casoli, L., Sabò, A., Moroni, M. C., Dellino, G. I., Amati, B., Nicassio, F., Lanfrancone, L. & Pelicci, P. G., Jan 15 2019, In : Cell Reports. 26, 3, p. 624-638.e8Research output: Contribution to journal › Article
Open Access
BRD4 and MYC-clarifying regulatory specificity
Sabò, A. & Amati, B., May 18 2018, In : Science. 360, 6390, p. 713-714 2 p.Research output: Contribution to journal › Review article
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma
Ravà, M., D’Andrea, A., Nicoli, P., Gritti, I., Donati, G., Doni, M., Giorgio, M., Olivero, D. & Amati, B., Jan 31 2018, In : Science Translational Medicine. 10, 426, eaan8723.Research output: Contribution to journal › Article